1. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004; 110:2747–2771. PMID:
15505111.
![crossref](/image/icon/bnr_ref_cross.gif)
2. Yellen ES, Gauvreau K, Takahashi M, et al. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics. 2010; 125:e234–e241. PMID:
20100771.
![crossref](/image/icon/bnr_ref_cross.gif)
3. Manlhiot C, Christie E, McCrindle BW, Rosenberg H, Chahal N, Yeung RS. Complete and incomplete Kawasaki disease: two sides of the same coin. Eur J Pediatr. 2012; 171:657–662. PMID:
22134803.
![crossref](/image/icon/bnr_ref_cross.gif)
4. Song D, Yeo Y, Ha K, et al. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age. Eur J Pediatr. 2009; 168:1315–1321. PMID:
19159953.
![crossref](/image/icon/bnr_ref_cross.gif)
5. Sudo D, Monobe Y, Yashiro M, et al. Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr. 2012; 171:651–656. PMID:
22159904.
![crossref](/image/icon/bnr_ref_cross.gif)
6. Witt MT, Minich LL, Bohnsack JF, Young PC. Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria. Pediatrics. 1999; 104:e10. PMID:
10390296.
![crossref](/image/icon/bnr_ref_cross.gif)
7. Zhang W, Li Q, Zhao XD, et al. Clinical analysis of 942 cases of Kawasaki disease. Zhonghua Er Ke Za Zhi. 2006; 44:324–328. PMID:
16780705.
8. Tremoulet AH, Jain S, Chandrasekar D, Sun X, Sato Y, Burns JC. Evolution of laboratory values in patients with Kawasaki disease. Pediatr Infect Dis J. 2011; 30:1022–1026. PMID:
21817952.
![crossref](/image/icon/bnr_ref_cross.gif)
9. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 1967; 16:178–222. PMID:
6062087.
10. Cha Y. Classification and diagnosis of red blood cell diseases. The Korean Society of Hematology. Hematology. 2nd ed. Seoul: Panmun Education;2011. p. 49.
11. Japan Kawasaki Disease Research Committee. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo: Ministry of Health and Welfare;1984.
12. Comenzo RL, Malachowski ME, Meissner HC, Fulton DR, Berkman EM. Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. J Pediatr. 1992; 120:926–928. PMID:
1593353.
![crossref](/image/icon/bnr_ref_cross.gif)
13. Kahwaji J, Barker E, Pepkowitz S, et al. Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients. Clin J Am Soc Nephrol. 2009; 4:1993–1997. PMID:
19833910.
![crossref](/image/icon/bnr_ref_cross.gif)
14. Nemeth E, Ganz T. Anemia of inflammation. [vi.]. Hematol Oncol Clin North Am. 2014; 28:671–681. PMID:
25064707.
![crossref](/image/icon/bnr_ref_cross.gif)
15. Sabharwal T, Manlhiot C, Benseler SM, et al. Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease. Am J Cardiol. 2009; 104:1743–1747. PMID:
19962487.
![crossref](/image/icon/bnr_ref_cross.gif)
16. Ha KS, Lee J, Jang GY, et al. Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease. Am J Cardiol. 2015; 116:301–306. PMID:
25975725.
![crossref](/image/icon/bnr_ref_cross.gif)
17. Terai M, Yasukawa K, Honda T, et al. Peripheral blood eosinophilia and eosinophil accumulation in coronary microvessels in acute Kawasaki disease. Pediatr Infect Dis J. 2002; 21:777–781. PMID:
12192168.
![crossref](/image/icon/bnr_ref_cross.gif)
18. Ashouri N, Takahashi M, Dorey F, Mason W. Risk factors for nonresponse to therapy in Kawasaki disease. J Pediatr. 2008; 153:365–368. PMID:
18534243.
![crossref](/image/icon/bnr_ref_cross.gif)
19. Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006; 149:237–240. PMID:
16887442.
![crossref](/image/icon/bnr_ref_cross.gif)
20. Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006; 113:2606–2612. PMID:
16735679.
![crossref](/image/icon/bnr_ref_cross.gif)
21. Sano T, Kurotobi S, Matsuzaki K, et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr. 2007; 166:131–137. PMID:
16896641.
![crossref](/image/icon/bnr_ref_cross.gif)
22. Tremoulet AH, Best BM, Song S, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr. 2008; 153:117–121. PMID:
18571548.
![crossref](/image/icon/bnr_ref_cross.gif)